» Articles » PMID: 36845859

Influence of Tricuspid Regurgitation After Heart Transplantation: A Single-center Experience

Overview
Publisher Wolters Kluwer
Specialty General Surgery
Date 2023 Feb 27
PMID 36845859
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: Between January 2008 and December 2015, 169 patients underwent orthotopic heart transplantation at our center and were included in this study. TVR trends and associated clinical parameters were retrospectively analyzed. TVR was assessed after 30 d, 1 y, 3 y, and 5 y, and groups were defined according to changes in TVR grade: constant (group 1; n = 100), improvement (group 2; n = 26), and deterioration (group 3; n = 43). Survival, outcome with regard to operative technique, and long-term kidney and liver function during follow-up were assessed.

Results: Mean follow-up time was 7.67 ± 4.17 y (median 8.62, Q1 5.06, Q3 11.16). Overall mortality was 42.0%, with differences between the groups ( < 0.01). Cox regression analysis revealed improvement of TVR as a significant predictor for survival (hazard ratio 0.23; 95% confidence interval, 0.08-0.63,  < 0.01). After 1 y 2.7%, after 3 y 3.7%, and after 5 y 3.9% of the patients showed persistent severe TVR. Creatinine levels after 30 d and 1, 3, and 5 y showed significant differences between the groups ( = 0.02,  < 0.01,  < 0.01, and  = 0.01), deterioration of TVR being associated with higher creatinine levels during follow-up.

Conclusions: Deterioration of TVR is associated with higher mortality and renal dysfunction. Improvement of TVR may function as a positive predictor for long-term survival after heart transplantation. Improvement of TVR should be a therapeutic goal offering a prognostic value for long-term survival.

Citing Articles

Tricuspid regurgitation after heart transplantation: where innovation and intervention are in hibernation.

Alyaydin E, Gotschy A, Parianos D, Nagele M, Tudorache I, Flammer A Heart Fail Rev. 2025; .

PMID: 39945978 DOI: 10.1007/s10741-025-10494-2.


Tricuspid Regurgitation after Orthotopic Heart Transplantation: Trajectories and Association With Mortality.

Belani K, Brinker V, Fuller M, Cooter M, Schroder J, Mamoun N Clin Transplant. 2025; 39(1):e70062.

PMID: 39777932 PMC: 11706220. DOI: 10.1111/ctr.70062.

References
1.
Filsoufi F, Salzberg S, Anderson C, Couper G, Cohn L, Adams D . Optimal surgical management of severe tricuspid regurgitation in cardiac transplant patients. J Heart Lung Transplant. 2006; 25(3):289-93. DOI: 10.1016/j.healun.2005.09.013. View

2.
Nguyen V, Cantarovich M, Cecere R, Giannetti N . Tricuspid regurgitation after cardiac transplantation: how many biopsies are too many?. J Heart Lung Transplant. 2005; 24(7 Suppl):S227-31. DOI: 10.1016/j.healun.2004.07.007. View

3.
Veen K, Quanjel T, Mokhles M, Bogers A, Takkenberg J . Tricuspid valve replacement: an appraisal of 45 years of experience. Interact Cardiovasc Thorac Surg. 2020; 30(6):896-903. DOI: 10.1093/icvts/ivaa033. View

4.
Algarni K, Arafat A, Pragliola C, AlHebaishi Y, Alfayez L, Alotaibi K . Tricuspid Valve Regurgitation After Heart Transplantation: A Single-Center 10-year Experience. J Saudi Heart Assoc. 2020; 32(2):213-218. PMC: 7640540. DOI: 10.37616/2212-5043.1058. View

5.
Russo M, Zilberszac R, Werner P, Kocher A, Wiedemann D, Schneider M . Isolated tricuspid valve regurgitation: old concepts, new insights and innovation. J Cardiovasc Med (Hagerstown). 2020; 21(6):406-414. DOI: 10.2459/JCM.0000000000000933. View